Evidence map›Paper›PMID 37742699›Full record

ArticleThe lancet. Gastroenterology & hepatology2023

Joint statement in support of hepatitis C human challenge studies.

Harvey J Alter, Eleanor Barnes, Mia J Biondi, Andrea L Cox, Jake D Eberts, Jordan J Feld, T Jake Liang, Josh Morrison, Charles M Rice, Naglaa H Shoukry and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The lancet. Gastroenterology & hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Calls for human challenge vaccine trials.Nature reviews. Gastroenterology & hepatology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Harvey J AlterTransfusion Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Eleanor BarnesNuffield Department of Medicine, University of Oxford, Oxford, UK.
Mia J BiondiSchool of Nursing, York University, Toronto, ON, Canada.
Andrea L CoxThe Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jake D Eberts1Day Sooner, Washington, DC, 20002, USA, University of Toronto, Toronto, ON, Canada. Electronic address: jake.eberts@1daysooner.org.
Jordan J FeldToronto Centre for Liver Disease, Toronto General Hospital, Toronto, ON, Canada.
T Jake LiangLiver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Josh Morrison1Day Sooner, Claymont, DE, USA.
Charles M RiceLaboratory of Virology and Infectious Disease, Rockefeller University, New York, NY, USA; Departments of Medicine and of Microbiology and Immunology, Université de Montréal, Montréal, QC, Canada.
Naglaa H ShoukryLaboratory of Liver Immunology, University of Montreal Hospital Research Centre (CRCHUM), Montréal, QC, Canada.
David L ThomasThe Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jennifer Van GennipAction Hepatitis Canada, Montréal, QC, Canada.
Charles WeijerDepartments of Philosophy, Medicine, and Epidemiology and Biostatistics, Western University, London, ON, Canada.
other signatories

Funding

The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunityU19AI159822 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2021 to 2025
$14.4M
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugsR01DA048063 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta, David L Thomas · 2019 to 2026
$4.2M
Leveraging HCV Phylogenetic Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject DrugsDP2DA053730 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI AKIYAMA, MATTHEW · 2021 to 2021
$2.5M
Medical Research Council MR/K01532X/1NIAID NIH HHS U19 AI159822NIDA NIH HHS DP2 DA053730NIDA NIH HHS R01 DA048063Wellcome Trust 206296/Z/17/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CHepacivirusHumans

Identifiers

PMID37742699
PMCPMC12931952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.